Trade Panbela Therapeutics, Inc. - PBLA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.06 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.2 |
| Open | 1.2 |
| 1-Year Change | 34.83% |
| Day's Range | 1.07 - 1.24 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 6, 2024 | 1.08 | -0.12 | -10.00% | 1.20 | 1.25 | 1.06 |
| Mar 5, 2024 | 1.20 | 0.01 | 0.84% | 1.19 | 1.23 | 1.16 |
| Mar 4, 2024 | 1.18 | -0.06 | -4.84% | 1.24 | 1.27 | 1.16 |
| Mar 1, 2024 | 1.23 | 0.08 | 6.96% | 1.15 | 1.29 | 1.14 |
| Feb 29, 2024 | 1.14 | -0.06 | -5.00% | 1.20 | 1.22 | 1.12 |
| Feb 28, 2024 | 1.16 | -0.02 | -1.69% | 1.18 | 1.22 | 1.14 |
| Feb 27, 2024 | 1.21 | 0.08 | 7.08% | 1.13 | 1.21 | 1.13 |
| Feb 26, 2024 | 1.12 | 0.01 | 0.90% | 1.11 | 1.14 | 1.07 |
| Feb 23, 2024 | 1.09 | 0.00 | 0.00% | 1.09 | 1.11 | 1.07 |
| Feb 22, 2024 | 1.08 | -0.05 | -4.42% | 1.13 | 1.13 | 1.08 |
| Feb 21, 2024 | 1.11 | -0.05 | -4.31% | 1.16 | 1.16 | 1.11 |
| Feb 20, 2024 | 1.15 | -0.05 | -4.17% | 1.20 | 1.20 | 1.13 |
| Feb 16, 2024 | 1.22 | -0.01 | -0.81% | 1.23 | 1.29 | 1.21 |
| Feb 15, 2024 | 1.25 | -0.11 | -8.09% | 1.36 | 1.38 | 1.19 |
| Feb 14, 2024 | 1.31 | 0.21 | 19.09% | 1.10 | 1.46 | 1.10 |
| Feb 13, 2024 | 1.11 | -0.02 | -1.77% | 1.13 | 1.13 | 1.09 |
| Feb 12, 2024 | 1.16 | -0.05 | -4.13% | 1.21 | 1.21 | 1.12 |
| Feb 9, 2024 | 1.20 | 0.10 | 9.09% | 1.10 | 1.22 | 1.08 |
| Feb 8, 2024 | 1.12 | -0.02 | -1.75% | 1.14 | 1.14 | 1.05 |
| Feb 7, 2024 | 1.14 | 0.00 | 0.00% | 1.14 | 1.17 | 1.08 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Panbela Therapeutics, Inc. Company profile
About Panbela Therapeutics Inc
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing disruptive therapeutics for the treatment of patients with cancer. The Company is engaged in the commercial development of a polyamine analogue for pancreatic cancer. Its product candidate includes SBP-101, which is a proprietary polyamine analogue that accumulates in the exocrine pancreas acinar cells due to its chemical structure. The Company is conducting Phase I a/I b study of the safety, efficacy and pharmacokinetics of SBP-101 administered in combination with two standard-of-care chemotherapy agents, gemcitabine and nab-paclitaxel.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Panbela Therapeutics Inc revenues was not reported. Net loss increased 70% to $6.6M. Higher net loss reflects Research and Development - Balancing increase of 90% to $3.2M (expense), General and administrative -Bal increase of 69% to $2.5M (expense), Other income decrease from $55K (income) to $611K (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
712 Vista Blvd # 305
55387
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com